TD1 isn’t a start-up. It is well past that stage, its backed by what was novita (listed on asx in 2004) and at least 25 years of inbuilt research.
TALi itself was founded in 2016, which would on the suggested 2 to 5 year timeframe mean that time is running out. TALi has made revenue in the past however took the foot off the sales pedal and relied on organic growth as focus was on trying to break into other markets.
Covid brought TALi‘s focus back to Australia and hence TALi is now in a second growth phase, not a start-up.
It needs to start making bank, or as others have said, the remaining investors will loose what confidence is left in TD1.
JMO as always DYOR
Tali Health 2020, page-1431
-
- There are more pages in this discussion • 860 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
-0.001(33.3%) |
Mkt cap ! $3.295M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $11 | 10.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 26068905 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 49518208 | 18 |
View Market Depth
| Last trade - 15.53pm 08/08/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |